Myung Jae Jeon

Prof. Myung Jae Jeon

Seoul National University Hospital
+1

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
SBS. W. Bai
S. W. Bai
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
JKJ. Y. Kim
J. Y. Kim
KCK. A. Chung
K. A. Chung
SKS. K. Kim
S. K. Kim
KPK. H. Park
K. H. Park

1 July 2008 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
HJHyun-Joo Jung
Hyun-Joo Jung
SCSue-Min Chung
Sue-Min Chung
SKSei-Kwang Kim
Sei-Kwang Kim
SBSang-Wook Bai
Sang-Wook Bai

1 April 2003 in Gynecologic Oncology
Verified
Journal Article
Closed access
MNM.I Suk Nam
M.I Suk Nam
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
Do Young KimDo Young Kim
Do Young Kim
JKJae Wook Kim
Jae Wook Kim
KPK.I Hyun Park
K.I Hyun Park
YHYoo Sun Hong
Yoo Sun Hong

3 April 2007 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
CKC.M. Kim
C.M. Kim
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
DCD.J. Chung
D.J. Chung
SKS.K. Kim
S.K. Kim
JKJ.W. Kim
J.W. Kim
SBS.W. Bai
S.W. Bai

5 December 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
MLMaria Lee
Maria Lee
EKEun Jae Kim
Eun Jae Kim
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1

1 February 2013 in Journal of Urology
Verified
Journal Article
Closed access
EKEun Jae Kim
Eun Jae Kim
NCNamhyun Chung
Namhyun Chung
SPSung Hyo Park
Sung Hyo Park
KLKyoung-Hee Lee
Kyoung-Hee Lee
SKSuhng Wook Kim
Suhng Wook Kim
Myung Jae JeonMyung Jae Jeon
Myung Jae Jeon
Biomechanical weakness of the pelvic supportive structures has been proposed to be a cause of pelvic organ prolapse. However, the molecular mechanism involved in these changes is not completely understood. In this investigation we evaluated oxidative stress biomarkers in the uterosacral ligaments of women with pelvic organ prolapse and compared them with those of women with normal support. In addition, mitochondrial apoptosis was examined. Samples were collected from 26 women with advanced stage pelvic organ prolapse and 29 age matched controls. The expression levels of 8-OHdG and 4-hydroxy-2-nonenal in the uterosacral ligaments were measured using immunohistochemistry. To assess mitochondrial apoptosis we performed TUNEL assay, immunohistochemistry for cleaved caspase-3 and cytochrome c, and Western blot analyses for cleaved caspase-3 and caspase-9. The mean percentage of cells immunopositive for 8-OHdG, 4-hydroxy-2-nonenal, TUNEL, cleaved caspase-3 and cytochrome c in the uterosacral ligaments was significantly higher in patients with pelvic organ prolapse than in controls. Similarly, Western blot analysis revealed increased expression of cleaved caspase-3 and caspase-9 in patients with pelvic organ prolapse. Correlation analyses revealed significant positive correlations between the percentage of cells immunopositive for 8-OHdG or 4-hydroxy-2-nonenal and markers of mitochondrial apoptosis. Analyzing by pelvic organ prolapse quantification system stage according to C point, the mean percentage of cells immunopositive for 8-OHdG, 4-hydroxy-2-nonenal and cytochrome c was significantly higher in patients with pelvic organ prolapse compared to controls, regardless of stage. However, the mean percentage of TUNEL and cleaved caspase-3 positive cells was significantly higher only in patients with stage III or IV pelvic organ prolapse. Oxidative stress and increased mitochondrial apoptosis may contribute to the pathological process of pelvic organ prolapse.